News

Published on 5 Nov 2023 on Insider Monkey via Yahoo Finance

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q3 2023 Earnings Call Transcript


Article preview image

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q3 2023 Earnings Call Transcript November 4, 2023

Operator: Good day, and welcome to the Kymera Therapeutics Third Quarter 2023 Results Call. [Operator Instructions]. Please note that this event is being recorded. I'd like to turn the conference over to Ms. Justine Koenigsberg, Vice President of Investor Relations. Please go ahead.

Justine Koenigsberg: Good morning, and welcome to Kymera's Quarterly Update. Joining me on this morning's call are Nello Mainolfi, Founder, President, and CEO; Jared Gollob, our Chief Medical Officer; and Bruce Jacobs, Chief Financial Officer. Following our remarks and presentation, we will open the call to questions. During the Q&A portion of the call, please limit your question to one and a related follow-up so that we will have enough time to address everyone's questions. Please note that we will be referencing slides in our corporate presentation during Jared's remarks. The slides can be accessed in the Investors section of our website, under Events and Presentations, and will be shown during the call for those on the webcast.

NASDAQ.KYMR price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Released Its First-Quarter Earnings: Here's What...

It's been a pretty great week for Kymera Therapeutics, Inc. (NASDAQ:KYMR) shareholders, with its ...

Simply Wall St. via Yahoo Finance 5 May 2024

Earnings call: Kymera Therapeutics reports progress in drug development By Investing.com

Kymera Therapeutics, during their first quarter 2024 earnings call, provided a comprehensive upda...

Investing.com 3 May 2024

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript May 3, 2024 Kymera Thera...

Insider Monkey via Yahoo Finance 3 May 2024

Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus

Kymera Therapeutics, Inc. KYMR reported a loss of 69 cents per share in the first quarter of 2024...

Zacks via Yahoo Finance 3 May 2024

Insider Sell: CFO Bruce Jacobs Sells 3,934 Shares of Kymera Therapeutics Inc (KYMR)

Kymera Therapeutics Inc (NASDAQ:KYMR) CFO Bruce Jacobs has sold 3,934 shares of the company's sto...

GuruFocus.com via Yahoo Finance 4 Mar 2024

Earnings Update: Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Reported And Analysts Are Trimming...

Investors in Kymera Therapeutics, Inc. (NASDAQ:KYMR) had a good week, as its shares rose 8.3% to ...

Simply Wall St. via Yahoo Finance 24 Feb 2024

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2023 Earnings Call Transcript

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2023 Earnings Call Transcript February 22, 2024 Kymera...

Insider Monkey via Yahoo Finance 23 Feb 2024

Kymera Therapeutics Inc (KYMR) Reports Q4 and Full Year 2023 Financial Results

Collaboration Revenues: Increased to $47.9 million in Q4 and $78.6 million for the full year 2023...

GuruFocus.com via Yahoo Finance 22 Feb 2024

Director Jeffrey Albers Sells 5,000 Shares of Kymera Therapeutics Inc (KYMR)

On February 21, 2024, Director Jeffrey Albers sold 5,000 shares of Kymera Therapeutics Inc (NASDA...

GuruFocus.com via Yahoo Finance 21 Feb 2024

Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Kymera Therapeu...

Zacks via Yahoo Finance 15 Feb 2024